179 related articles for article (PubMed ID: 34553515)
21. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
Horn R; Bertin FR
J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
[TBL] [Abstract][Full Text] [Related]
22. PITUITARY PARS INTERMEDIA DYSFUNCTION (EQUINE CUSHING'S DISEASE) IN NONDOMESTIC EQUIDS AT MARWELL WILDLIFE: A CASE SERIES. ONE CHAPMAN'S ZEBRA ( EQUUS QUAGGA CHAPMANI) AND FIVE PRZEWALSKI's HORSES ( EQUUS FERUS PRZEWALSKII).
Shotton JCR; Justice WSM; Salguero FJ; Stevens A; Bacci B
J Zoo Wildl Med; 2018 Jun; 49(2):404-411. PubMed ID: 29900762
[TBL] [Abstract][Full Text] [Related]
23. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA
Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311
[TBL] [Abstract][Full Text] [Related]
24. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy.
Fortin JS; Hetak AA; Duggan KE; Burglass CM; Penticoff HB; Schott HC
Sci Rep; 2021 Aug; 11(1):16036. PubMed ID: 34362943
[TBL] [Abstract][Full Text] [Related]
25. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
26. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
[TBL] [Abstract][Full Text] [Related]
27. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
28. Relationships of inflamm-aging with circulating nutrient levels, body composition, age, and pituitary pars intermedia dysfunction in a senior horse population.
Siard-Altman MH; Harris PA; Moffett-Krotky AD; Ireland JL; Betancourt A; Barker VD; McMurry KE; Reedy SE; Adams AA
Vet Immunol Immunopathol; 2020 Mar; 221():110013. PubMed ID: 32058159
[TBL] [Abstract][Full Text] [Related]
29. Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction.
Huang L; Palmieri C; Bertin FR
Res Vet Sci; 2022 Dec; 152():427-433. PubMed ID: 36126509
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
Beech J; Boston R; Lindborg S
J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
[TBL] [Abstract][Full Text] [Related]
31. Effect of delayed plasma centrifugation on equine adrenocorticotropic hormone concentration.
Shepard KN; Haffner JC; Neal DL; Grubbs ST; Pearce GL
J Vet Diagn Invest; 2019 Jul; 31(4):585-587. PubMed ID: 31246158
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
Donaldson MT; Jorgensen AJ; Beech J
J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
[TBL] [Abstract][Full Text] [Related]
33. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
Lee ZY; Zylstra R; Haritou SJ
Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
[TBL] [Abstract][Full Text] [Related]
34. FDA-CVM works to address concerns about pergolide supplies.
J Am Vet Med Assoc; 2007 Jul; 231(1):20-1. PubMed ID: 17668498
[No Abstract] [Full Text] [Related]
35. Perianesthetic development of diaphragmatic hernia in a horse with equine pituitary pars intermedia dysfunction (PPID).
Shepard MK; Lee WL; Eggleston RB
Can Vet J; 2015 Jan; 56(1):48-52. PubMed ID: 25565714
[TBL] [Abstract][Full Text] [Related]
36. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses.
Miller C; Utter ML; Beech J
Am J Vet Res; 2013 Jul; 74(7):1030-5. PubMed ID: 23802675
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of equine pituitary pars intermedia dysfunction.
Stewart AJ; Ireland JL; Durham AE; McGowan CM
Vet J; 2023; 300-302():106036. PubMed ID: 37805159
[TBL] [Abstract][Full Text] [Related]
39. Influence of feeding and other factors on adrenocorticotropin concentration and thyrotropin-releasing hormone stimulation test in horses and ponies.
Drozdzewska K; Winter J; Barton AK; Merle R; Gehlen H
Equine Vet J; 2024 Mar; 56(2):342-351. PubMed ID: 38010866
[TBL] [Abstract][Full Text] [Related]
40. Successful medical treatment of an Aspergillus terreus mycetoma of the nostril/lip in a 16-year-old Fjord pony gelding with pituitary pars intermedia dysfunction.
Randleff-Rasmussen PK; Mosca M; Knoerr F; Pin D; Desjardins I
Vet Dermatol; 2017 Dec; 28(6):629-e155. PubMed ID: 28736852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]